The British journal of dermatology · 2026
K17 hi Hair Follicle Cells Orchestrate Psoriatic Inflammation Through S100A1-Dependent Signaling.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tang Xin, Qiao Pei, Liu Wanting, Yang Yang, Gu Yunfeng, Mao Xiaojuan, Quan Huiyi, Luo Yixin, Xue Ke, Guo Yanyang, Gudjonsson Johann E, Li Zhiguo, Wang Gang, Shao Shuai
Аннотация
BACKGROUND: Psoriasis is a chronic inflammatory skin disease with frequent and refractory scalp involvement, but the mechanisms underlying regional susceptibility remain unclear.
OBJECTIVES: To define the role of hair follicle cell (HFC) subsets in psoriatic inflammation and uncover their pathogenic mechanisms.
METHODS: We integrated bulk, single-cell and spatial transcriptomic data from healthy and psoriatic human skin across multiple anatomical sites. HFC subsets and regulatory programmes were profiled through single-cell analyses, and key molecular interactions and functional effects were validated by computational modeling, in vitro assays, and in vivo mouse models.
RESULTS: Five HFC subsets were identified, including K15hi hair follicle stem cells, K17hi, SPINK5hi, K23hi, and MT2Ahi HFCs. Among them, K17hi HFCs were markedly expanded in perilesional and lesional psoriatic skin and were preferentially distributed along a psoriasis-associated pseudotime trajectory enriched for pro-inflammatory programmes. Healthy scalp skin showed increased HFC abundance and preferential enrichment of K17hi HFCs compared with other anatomical sites, which was further enhanced in scalp psoriasis. S100A1, the top differentially expressed gene in K17hi HFCs, was regulated by TCF12 and mediated annexin A2 (ANXA2)-dependent CD4+ T cell activation and tissue-resident memory features. K17 perturbation further supported the upstream regulation of the TCF12-S100A1 axis, whereas ANXA2 blockade attenuated S100A1-induced T-cell responses. Topical S100a1 knockdown alleviated imiquimod (IMQ)-induced psoriasiform inflammation in vivo.
CONCLUSION: K17 hi HFCs form a region-enriched pro-inflammatory niche that contributes to psoriasis through the TCF12-S100A1-ANXA2 follicular-immune axis. Targeting this axis may provide a potential therapeutic strategy for difficult-to-treat psoriasis.
OBJECTIVES: To define the role of hair follicle cell (HFC) subsets in psoriatic inflammation and uncover their pathogenic mechanisms.
METHODS: We integrated bulk, single-cell and spatial transcriptomic data from healthy and psoriatic human skin across multiple anatomical sites. HFC subsets and regulatory programmes were profiled through single-cell analyses, and key molecular interactions and functional effects were validated by computational modeling, in vitro assays, and in vivo mouse models.
RESULTS: Five HFC subsets were identified, including K15hi hair follicle stem cells, K17hi, SPINK5hi, K23hi, and MT2Ahi HFCs. Among them, K17hi HFCs were markedly expanded in perilesional and lesional psoriatic skin and were preferentially distributed along a psoriasis-associated pseudotime trajectory enriched for pro-inflammatory programmes. Healthy scalp skin showed increased HFC abundance and preferential enrichment of K17hi HFCs compared with other anatomical sites, which was further enhanced in scalp psoriasis. S100A1, the top differentially expressed gene in K17hi HFCs, was regulated by TCF12 and mediated annexin A2 (ANXA2)-dependent CD4+ T cell activation and tissue-resident memory features. K17 perturbation further supported the upstream regulation of the TCF12-S100A1 axis, whereas ANXA2 blockade attenuated S100A1-induced T-cell responses. Topical S100a1 knockdown alleviated imiquimod (IMQ)-induced psoriasiform inflammation in vivo.
CONCLUSION: K17 hi HFCs form a region-enriched pro-inflammatory niche that contributes to psoriasis through the TCF12-S100A1-ANXA2 follicular-immune axis. Targeting this axis may provide a potential therapeutic strategy for difficult-to-treat psoriasis.